Analystreport

Galena Biopharma, Inc. (NYSE: SLS) had its "buy" rating re-affirmed by analysts at HC Wainwright.

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report